Athersys’ MultiStem® Promotes Recovery After Acute Spinal Cord Injury in Preclinical Study

Posted byclientekdevPosted instem cell research

http://globenewswire.com/news-release/2015/11/19/788698/0/en/Athersys-MultiStem-Promotes-Recovery-After-Acute-Spinal-Cord-Injury-in-Preclinical-Study.html

CLEVELAND, Nov. 19, 2015 (GLOBE NEWSWIRE) — Athersys, Inc. (Athersys) (NASDAQ:ATHX) announced today that multipotent adult progenitor cells (MAPC®), used in Athersys’ MultiStem® cell therapy currently in clinical development, are effective in improving the health of animals after acute rodent spinal cord injury. Intravenous administration of MAP…